CDK9 is dispensable for YAP-driven hepatoblastoma development.
Chen X, Kiss A, Schaff Z, Evert K, Zhang Y, Zhong S, Wang J, Evert M, Calvisi DF, Chen X.
Chen X, et al. Among authors: kiss a.
Pediatr Blood Cancer. 2020 May;67(5):e28221. doi: 10.1002/pbc.28221. Epub 2020 Mar 2.
Pediatr Blood Cancer. 2020.
PMID: 32124532